Cipla Ltd. — Board/Management Information 2021

May 14, 2021

14[th] May, 2021

(1) BSE Ltd. (2) National Stock Exchange of India Ltd. Listing Department Listing Department Phiroze Jeejeebhoy Towers Exchange Plaza, 5[th] floor, Dalal Street Plot no. C/1, G Block, Mumbai 400 001 Bandra Kurla Complex, Bandra (East), Mumbai - 400 051 Scrip Code: 500087 Scrip Code: CIPLA

(3) SOCIETE DE LA BOURSE DE LUXEMBERG Societe Anonyme 35A Boulevard Joseph II, L-1840 Luxembourg

Dear Sir/Madam,

Sub: Appointment of Director

In compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that based on the recommendation of Nomination and Remuneration Committee and subject to approval of the shareholders at the ensuing Annual General Meeting, the Board of the Directors of the Company at its meeting held today i.e. 14[th] May 2021, has approved appointment of Mr. Robert A. Stewart (DIN: 03515778) as an additional and an independent director of the Company for period of 5 years with effect from 14[th] May, 2021 to 13[th] May 2026 (both days inclusive).

The details as required under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/ CMD/ 4/ 2015 dated 9[th] September, 2015, including the brief profile of Mr. Stewart are given in Annexure A to this letter.

Thanking you,

Yours faithfully, For Cipla Limited Digitally signed by RAJENDR RAJENDRA CHOPRA A CHOPRA Date: 2021.05.14 19:14:06 +05'30'

Rajendra Chopra Company Secretary Encl.: as above

Prepared by: Nishtha Agarwal

Annexure A

		Annexure A
	Name of the Director	Robert A. Stewart
	DIN	03515778
	Reasonforchangeviz.appointment,resignation,removal, death or otherwise	Appointment of Mr. Robert A. Stewart(DIN: 03515778), as anadditional and an Independent Director of the Company for aperiod of five (5) years w.e.f. 14thMay 2021 to 13thMay 2026(both days inclusive);
	,
	Date of appointment /cessation(asapplicable)&termofappointment	Period of five (5) years commencing from 14thMay 2021 to13thMay 2026.He would not be liable to retire by rotation.
	Brief profile	Robert Stewart has over 34 years of experience in thebiopharmaceutical industry having worked with leadingcompanies such as Roche, Abbott, Watson / Actavis /Allergan, Amneal and Theramex. Currently, Robert is theChief Executive Officer at Theramex Ltd, a global specialtypharmaceutical company.Robert has deep expertise in manufacturing operations,quality, supply chain and general management and a verystrong exposure to commercial operations. He has served onthe boards of several industry and non-profit organizationsand served for nearly two years on the Amneal board ofdirectors.Robert has a B.S., Business Management from FairleighDickinson University, New Jersey.
	Disclosureofrelationshipsbetween directors (in case ofappointment of a director).	Mr Robert A. Stewart has no relationship with any otherdirectors of the company.
	Information as required pursuantto BSE Circular with ref. no. LIST/COMP/ 14/ 2018- 19 and theNational Stock Exchange of IndiaLtd with ref. no. NSE/ CML/2018/24, dated 20th June2018	Mr. Robert Stewart is not debarred from holding the office ofdirector by virtue of any SEBI order or any other suchauthority.